[1] 中华医学会儿科学分会感染学组,《中华儿科杂志》编辑委员会. 中国儿童百日咳诊断及治疗建议[J]. 中华儿科杂志, 2017, 55(8):568-572. [2] FRY NK, CAMPBELL H, AMIRTHALINGAM G.JMM Profile: Bordetella pertussis and whooping cough (pertussis): still a significant cause of infant morbidity and mortality, but vaccine-preventable[J]. J Med Microbiol, 2021, 70(10):001442. [3] MATTIA DG, NICOLAI A, FRASSANITO A, et al.Pertussis: New preventive strategies for an old disease[J]. Paediatr Respir Rev, 2019, 29:68-73. [4] 宁桂军, 高源, 吴丹, 等. 中国2011-2017年百日咳流行病学特征分析[J]. 中国疫苗和免疫, 2018, 24(3):264-267,273. [5] 中华预防医学会, 中华预防医学会疫苗与免疫分会. 中国百日咳行动计划专家共识[J]. 中华流行病学杂志, 2021, 42(6):955-965. [6] 张倩, 吴丹, 郑徽, 等.中国2022年百日咳流行病学特征[J].中国疫苗和免疫, 2024, 30(1):34-38. [7] 朱可怡, 李昱, 陈操, 等. 2024年3月中国需关注的突发公共卫生事件风险评估[J]. 疾病监测, 2024, 39(3):261-263. [8] CHERRY JD, WENDORF K, BREGMAN B, et al.An Observational Study of Severe Pertussis in 100 Infants ≤120 Days of Age.[J]. Pediatr Infect Dis, 2018, 37(3):202-205. [9] 陈一然, 邓继岿. 百日咳家庭聚集发病2例[J/CD]. 新发传染病电子杂志, 2023, 8(2):68-70. [10] 中华医学会感染病学分会儿科感染学组, 国家卫生健康委能力建设和继续教育儿科专委会感染组, 中国临床实践指南联盟方法学专委会, 等. 中国百日咳诊疗与预防指南(2024版)[J]. 中华医学杂志, 2024, 104(15):1258-1279. [11] 李宏森, 梁疆莉, 杨净思. 百日咳流行病学特征及防控进展[J]. 中国生物制品学杂志, 2024, 37(3):361-369. [12] BECHINI A, TISCIONE E, BOCCALINI S, et al.Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations.[J]. Vaccine, 2012, 30(35):5179-5190. [13] 张艳炜, 梁静, 卢紫燕, 等. 不同免疫状态和年龄对百日咳患儿临床表现的影响[J]. 中华传染病杂志, 2020, 38(7):440-443. [14] 张继燕, 卓裕霏, 陈艳萍, 等. 儿童百日咳住院病例248例临床特征及重症百日咳相关危险因素分析[J]. 中华实用儿科临床杂志, 2023, 38(4):275-280. [15] ZHANG C, ZONG Y, WANG Z, et al.Risk factors and prediction model of severe pertussis in infants <12 months of age in Tianjin, China[J]. BMC Infect Dis, 2022, 22(1):24-24. [16] KANG L, CUI X, FU J, et al.Clinical charac-teristics of 967 children with pertussis: a single-center analysis over an 8-year period in Beijing, China.[J]. Eur J Clin Microbiol Infect Dis, 2022, 41(1): 9-20. [17] 曹宪振, 马杰彦, 胡亮, 等. 2108例儿童呼吸道病原体感染的流行病学特征[J/CD]. 新发传染病电子杂志, 2024, 9(1):12-16. [18] 彭晓康, 刘小乖, 李亚绒, 等. 合并其他病原感染的百日咳患儿临床特征与炎症指标特点[J]. 中国妇幼健康研究, 2020, 31(8):1089-1093. [19] KROES MM, VAN VLIET LC, JACOBI RHJ, et al.Long Lasting Antibodies From Convalescent Pertussis Patients Induce ROS Production and Bacterial Killing by Human Neutrophils[J]. Front Cell Infect Microbiol, 2022, 12: 888412-888412. [20] EBY JC, HOFFMAN CL, GONYAR LA, et al. Review of the neutrophil response to Bordetella pertussis infection[J]. Pathog Dis, 2015, 73(9):ftv081. [21] TIAN SF, WANG HM, DENG JK.Fatal malignant pertussis with hyperleukocytosis in a Chinese infant: A case report and literature review[J].Medicine, 2018, 97(17):e0549. [22] SHI T, DU S, FAN H, et al.Risk Factors of Exchange Blood Transfusion in Infants With Severe Pertussis[J]. Clin Pediatr (Phila), 2023, 62(10):1245-1253. [23] LIU C, YANG L, CHENG Y, et al.Risk factors associated with death in infants 120 days old with severe pertussis: a case-control study[J]. BMC Infect Dis,2020,20(1):852. [24] 姚开虎, 李丽君. 重症百日咳的诊断及其死亡风险因素研究进展[J]. 中华实用儿科临床杂志, 2019, 34(22):1681-1685. [25] 刘辉,方訸平,闫军. 70例儿童重症百日咳临床特点分析[J]. 重庆医学, 2022, 51(18):3187-3190. [26] PADDOCK CD, SANDEN GN, CHERRY JD, et al.Pathology and pathogenesis of fatal Bordetella pertussis infection in infants[J]. Clin Infect Dis, 2008, 47(3):328-338. [27] 王静娟, 米荣, 崔小岱, 等. 婴幼儿重症百日咳研究进展[J]. 中华实用儿科临床杂志, 2022, 37(17):1351-1354. |